Investor Presentaiton

Specialised & Premium Wellness are the fastest growing segments METROPOLIS The Pathology Specialist Our Brand Equity across markets & Doctors Trust and Reliance on Metropolis helps us grow our Specialized & Premium Wellness segment faster than the Industry growth Q3FY22 Q3FY23 Revenue excl. Covid PCR & Covid Allied tests Volume Mix 14% 2% 47% 14% 2% 38% Q3FY22 Q3FY23 Non-Covid Revenue (excl. PPP Contract & Hi-tech Acquisition) Volume Mix 11% 2% 50% 11% 2% 49% 48% 36% 38% Value Mix 10% 13% 18% 17% 36% 36% 39% 31% Routine Semi-Specialized Specialized Wellness & Others 37% Value Mix 12% 19% 14% 19% 33% 33% 34% 36% Our wide and extensive tests menu enables us to cater to every customer profile from routine to complex specialized tests Our contribution from Premium Wellness in terms of value (excl. Covid PCR & Covid Allied tests, PPP Contracts & Hi-Tech) has increased from 12% in Q3FY22 to 14% in Q3FY23 Q3FY22 includes Hitech Diagnostics w.e.f 22nd Oct 2021 13

View entire presentation